Author

Nicholas Lillis

University of California, San FranciscoORCID 0009-0008-0054-264XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Alden King-Yung LeungiD· 1 shared Alina NaveediD· 1 shared Andrej BenjakiD· 1 shared Bence DánieliD· 1 shared Charlotte K.Y. NgiD· 1 shared D. A. Quigley· 1 shared Giada Andrea CassanmagnagoiD· 1 shared Haiyuan YuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alden King-Yung LeungORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedJan 14, 2026

A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules

Phillip Thienger, Irene Paassen, Xiaosai Yao…·Mark A. Rubin

This study identifies a SWI/SNF-targeting therapy effective against a double-negative prostate cancer subtype, showing it reduces viability in both AR-dependent and WNT-dependent models.

11 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky